Complementary Therapies in Clinical Practice
Volume 15, Issue 2 , Pages 72-75 , May 2009

Effect of craniosacral therapy on lower urinary tract signs and symptoms in multiple sclerosis

  • Gil Raviv

      Affiliations

    • Urology Department, Sheba Medical Center, Tel Hashomer, Affiliated to the Sackler School of medicine, Tel Aviv University, Israel
    • Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Affiliated to the Sackler School of medicine, Tel Aviv University, Israel
    • Corresponding Author InformationCorresponding author. Urology Department, Sheba Medical Center, Tel Hashomer, Affiliated to the Sackler School of medicine, Tel Aviv University, Israel. Tel.: +972 3 530 2231; fax: +972 3 535 1892.
    • ,
  • Shai Shefi

      Affiliations

    • Urology Department, Sheba Medical Center, Tel Hashomer, Affiliated to the Sackler School of medicine, Tel Aviv University, Israel
    • ,
  • Dalia Nizani

      Affiliations

    • Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Affiliated to the Sackler School of medicine, Tel Aviv University, Israel
    • ,
  • Anat Achiron

      Affiliations

    • Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Affiliated to the Sackler School of medicine, Tel Aviv University, Israel

References 

  1. Quarto G, Autorino R, Gallo A, De Sio M, D'Armiento M, Perdonà S, et al. Quality of life in women with multiple sclerosis and overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:189–194
  2. Kragt JJ, Hoogervorst EL, Uitdehaag BM, Polman CH. Relation between objective and subjective measures of bladder dysfunction in multiple sclerosis. Neurology. 2004;63:1716–1718
  3. Fingerman JS, Finkelstein LH. The overactive bladder in multiple sclerosis. J Am Osteopath Assoc. 2000;100(3 Suppl):S9–S12
  4. Lemack GE, Frohman EM, Zimmern PE, Hawker K, Ramnarayan P. Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis. Urology. 2006;67:960–964
  5. de Seze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B. International Francophone Neuro-Urological expert study group (GENULF). The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13:915–928
  6. Ethans KD, Nance PW, Bard RJ, Casey AR, Schryvers OI. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med. 2004;27:214–218
  7. Horstmann M, Schaefer T, Aguilar Y, Stenzl A, Sievert KD. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol Urodyn. 2006;25:441–445
  8. Fader M, Glickman S, Haggar V, Barton R, Brooks R, Malone-Lee J. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial. J Urol. 2007;177:208–213
  9. Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC. Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil. 2003;17:181–191
  10. Upledger JE, Vredevoogd J. Craniosacral therapy. Seattle: Eastland Press; 1983;
  11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  12. Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG. Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther. 2005;22:381–394
  13. Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Vespasiani G, Castellano V. Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients. Neurourol Urodyn. 1998;17:89–98
  14. Blaivas JG, Kaplan SA. Urologic dysfunction in patients with multiple sclerosis. Semin Neurol. 1988;8:159–165
  15. McGuire EJ, Savastano JA. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction. J Urol. 1984;132:713–715
  16. Alhasso AA, McKinlay J, Patrick K, Stewart L. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2006;4:CD003193
  17. McClurg D, Ashe RG, Marshall K, Lowe-Strong AS. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn. 2006;25:337–348
  18. Yagci S, Kibar Y, Akay O, Kilic S, Erdemir F, Gok F, et al. The effect of biofeedback treatment on voiding and urodynamic parameters in children with voiding dysfunction. J Urol. 2005;174:1994–1997

PII: S1744-3881(08)00120-5

doi: 10.1016/j.ctcp.2008.12.006

Complementary Therapies in Clinical Practice
Volume 15, Issue 2 , Pages 72-75 , May 2009

Article Tools

* Image Usage & Resolution